WE ARE HIRING

Open positions

StatFinn - EPID Research is now IQVIA. We offer a full range of services in Clinical Trial Biostatistics and Data Management, Epidemiology and Real-World Evidence that covers the drug development life cycle – from Phase I to Phase IV and beyond. Our clients are leading pharmaceutical and biotechnology companies worldwide.

We are offering opportunities to work with the leading international healthcare organizations and the latest healthcare trends in a dynamic and flexible environment of a growing expert company. With us you can be part of our local organization with global career opportunities. If you are interested in human data science and driving drug development and healthcare forward, this would be an ideal place for you.

Finland

Espoo or Turku

Sweden

Gothenburg
No open positions available.

Estonia

Tallinn or Tartu
Are you interested in learning more about how our RWE solutions can help you in your drug development and surveillance? Our team of experts is eager to discuss your specific needs. To learn more, please contact us at office@epidresearch.com.

Other career opportunities

If you are interested in other career opportunities at EPID Research, please send your open application with your cv to careers@epidresearch.com.

If you are interested in career opportunities at StatFinn, please see StatFinn careers.


It’s important for us to respect your privacy and comply with the requirements of EU’s General Data Protection Regulation (GDPR). Your application and CV will be stored electronically in servers located within EU and handled during the recruitment process. The information is being processed by HR representatives and the hiring manager responsible for the open position. The application will be stored in our database for one year. If you have expressed your interest in other open positions as well in your application letter or with an open application, your application will be available to our recruiters for one year. Your data will be deleted from our database after this one-year period. For more information on our privacy notice see here.